Titre:
  • Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab
Auteur:Heinrichs, Amélie; Dessars, Barbara; El Housni, Hakim; Pluymers, Wim; Peeters, Karen; Benghiat, Fleur; Heimann, Pierre
Informations sur la publication:Leukemia research, 67, page (27-31)
Statut de publication:Publié, 2018-04
Sujet CREF:Cancérologie
Hématologie
Mots-clés:Chronic myeloid leukemia
Discontinuation
EUTOS
Imatinib
Real-life deep molecular response
Treatment-free remission
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0145-2126
info:doi/10.1016/j.leukres.2018.01.018
info:pii/S0145212618300249
info:scp/85041655505